Working in partnership with nursing home sector to facilitate improved wound management with the introduction of Bioactive Microfibre Gelling (BMG™) technology
Tissue Viability is an area of healthcare that has synergy with many medical specialties and care settings.
Our team covers 53 nursing homes across our trust, locations are both large and widespread.
Patients with increased care needs are now being discharged faster from hospital into the community and nursing home staff are often not prepared for this.
Challenges facing wound management within this care setting involve continuity of staff, use of agency staff and high staff turnover. Education to the nursing home sector has been an issue during and since the pandemic.
As a team we recognise the importance of ensuring that clinicians have every opportunity to access new innovative products and training and we are committed to the provision of support to service, clinical and patient needs.
To provide ‘in use’ clinical data to establish if a new BMG fibre technology dressing (MaxioCel) could facilitate improved wound management objectives in patients with chronic wounds in nursing homes via case study series over a 4 week period.
Over a 4 week evaluation period, clinicians noted:
- Improvement in wound bed preparation, healing trajectory and enhanced status of the periwound skin.
- Pain levels were reduced and, as a consequence, patient reported outcomes improved.
- Dressing flexibility and conformability allowed comfort and patient satisfaction aligned with increased quality of life and undisturbed healing.
- Effective in the management of moderate-to-high exudate, increased patient comfort and quality of life.
- Painless and atraumatic removal of the dressing, increasing patient comfort, both during wear time and at dressing removal.
53 year old male with deep vein thrombosis, osteomyelitis, pulmonary embolism, spinabifida, scoliosis of the spine, essential hypertension. BMI>35.
Patient had 2 x category 3 sacral pressure ulcers static, non-healing for six months.
Maintaining a clean wound for this patient was crucial to prevent wound infection.
Previous medical interventions included foam dressings due to patients sensitive skin and reactions to other adhesives. Dressings being changed daily.
MaxioCel was commenced with treatment aims to manage exudate and promote healing. Prevention of infection was also key for this patient, due to high risk location of wounds.
Over an evaluation period of four weeks, exudate levels lowered from moderate-high to low, having a positive impact on the condition of periwound skin.
MaxioCel autolytically debrided slough and wound bed necrosis, facilitating more clearly defined wound management objectives. Granulating tissue was protected.
Nursing home staff really embraced the evaluation. They were excited, enthusiastic and impressed with how MaxioCel progressed the wounds and the improvement it made. The staff absorbed the information and followed the advice given to the letter. All participating clinicians indicated that they would continue to use MaxioCel as an excellent all-rounder.
To see the full poster, presented at Wound Care Today 2023, including more details on the case study highlighted, download below.